Gao Qianmin, Wang Jian, Zhang Hao, Wang Jianhua, Jing Yingying, Su Jiacan
Institute of Translational Medicine, Shanghai University, Shanghai, 200444, P. R. China.
Organoid Research Center, Shanghai University, Shanghai, 200444, P. R. China.
Adv Healthc Mater. 2025 Aug;14(20):e2500301. doi: 10.1002/adhm.202500301. Epub 2025 Apr 26.
Organoids provide 3D structures that replicate native tissues in biomedical research. The development of vascular networks within organoids enables oxygen and nutrient delivery while facilitating metabolic waste removal, which supports organoid growth and maturation. Recent studies demonstrate that vascularized organoid models offer insights into tissue interactions and promote tissue regeneration. However, the current limitations in establishing functional vascular networks affect organoid growth, viability, and clinical translation potential. This review examines the development of vascularized organoids, including the mechanisms of angiogenesis and vasculogenesis, construction strategies, and biomedical applications. The approaches are categorized into in vivo and in vitro methods, with analysis of their specific advantages and limitations. The review also discusses emerging techniques such as bioprinting and gene editing for improving vascularization and functional integration in organoid-based therapies. Current developments in organoid vascularization indicate potential applications in modeling human diseases and developing therapeutic strategies, contributing to advances in translational research.
类器官提供了在生物医学研究中复制天然组织的三维结构。类器官内血管网络的形成能够实现氧气和营养物质的输送,同时促进代谢废物的清除,从而支持类器官的生长和成熟。最近的研究表明,血管化类器官模型有助于深入了解组织间相互作用并促进组织再生。然而,目前在建立功能性血管网络方面的局限性影响了类器官的生长、存活能力以及临床转化潜力。本综述探讨了血管化类器官的发展,包括血管生成和血管发生的机制、构建策略以及生物医学应用。这些方法分为体内和体外方法,并分析了它们各自的优势和局限性。该综述还讨论了诸如生物打印和基因编辑等新兴技术,这些技术可用于改善基于类器官的治疗中的血管化和功能整合。类器官血管化的当前进展表明其在人类疾病建模和治疗策略开发中的潜在应用,有助于推动转化研究的进步。
Adv Healthc Mater. 2025-8
Clin Transl Med. 2025-3
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024
J Orthop Translat. 2025-8-14
Adv Healthc Mater. 2025-6
Stem Cell Res Ther. 2023-11-19
Clin Res Hepatol Gastroenterol. 2025-7-2
Front Bioeng Biotechnol. 2025-7-23